FDA, HHS Advisory Board Meeting on a Nonprescription Birth Control Pill

The Food and Drug Administration (FDA) and Department of Health and Human Services hold a public advisory committee meeting of the Nonprescription Drugs Advisory Committee and the Obstetrics, Reproductive and Urologic Drugs Advisory Committee from 9:30 a.m. to 5:30 p.m. ET on May 9. The committees discuss supplemental new drug a...